New Jer­sey biotech plans for tiny IPO; Vir gets $10M Gates Foun­da­tion grant for HIV vac­cine

Chro­mo­cell Ther­a­peu­tics, based in North Brunswick, New Jer­sey, plans to go pub­lic, ac­cord­ing to an SEC fil­ing.

Ac­cord­ing to its LinkedIn …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA